Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
111,633,839
-
Number of holders
-
184
-
Total 13F shares, excl. options
-
83,480,362
-
Shares change
-
+2,141,392
-
Total reported value, excl. options
-
$2,370,707,599
-
Value change
-
+$83,198,140
-
Put/Call ratio
-
1.77%
-
Number of buys
-
102
-
Number of sells
-
-72
-
Price
-
$28.4
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q3 2018
217 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q3 2018.
Evolent Health, Inc. - Class A Common Stock (EVH) has 184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83,480,362 shares
of 111,633,839 outstanding shares and own 74.78% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (7,642,195 shares), JPMORGAN CHASE & CO (7,194,494 shares), Vanguard Group Inc (5,713,530 shares), Bank of New York Mellon Corp (5,512,817 shares), BlackRock Inc. (4,571,771 shares), RIVERBRIDGE PARTNERS LLC (3,431,509 shares), DIMENSIONAL FUND ADVISORS LP (3,187,652 shares), EAGLE ASSET MANAGEMENT INC (2,540,837 shares), FMR LLC (2,401,826 shares), and BLAIR WILLIAM & CO/IL (2,141,271 shares).
This table shows the top 184 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.